Are Options Traders Bullish on AQXP?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About AQXP

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Aquinox's lead drug candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing slated to enter Phase 3 clinical trials in 2016 for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC); a debilitating, chronic condition that is estimated to affect millions of sufferers. Aquinox has a broad intellectual property portfolio surrounding compounds that activate SHIP1
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmacies and Drug Stores

AQXP is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 15.1 B 1.51286E+10 3,419 3419 0.0% 0 11 K 11211
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.8 B 1.8E+09 1,028 1028 0.0% 5.53676E-06 10 K 9772
SBIO ALPS Medical Breakthroughs ETF 219.4 M 2.19399E+08 112 112 0.04% 0.0004 88 K 87760
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.4 B 1.35343E+09 1,904 1904 0.0% 9E-06 12 K 11642

Wait, Before You Leave...